6 in 10 readers want to see paracetamol made a P medicine

A C+D poll has shown that 59% of pharmacists believe paracetamol should no longer be sold by non-pharmacy retailers

paracetamol_1066168.jpg
A C+D investigation revealed that half of 12 non-pharmacy retailers were willing to breach MHRA guidelines
EXCLUSIVE

Almost six in 10 C+D readers believe paracetamol should only be sold in pharmacies, a poll has revealed.

Fifty-nine per cent of 272 respondents to a poll, posted on the C+D website between November 27 and December 1, agreed that paracetamol should no longer be sold by non-pharmacy retailers.

C+D conducted the poll in the wake of its investigation last month that revealed that half of 12 high-street retailers were willing to sell three 16-tablet packs of the drug. Voluntary guidelines by the Medicines and Healthcare products Regulatory Agency (MHRA) state that a maximum of two packs should be sold in a single transaction. 

Poundland, Tesco, Sainsbury’s, 99p Stores, Costcutter and a Londis corner shop were all willing to sell three packs of the analgesic, while the Co-operative Food, Morrisons, Lidl, Aldi, Waitrose and Asda conformed to the MHRA’s best practice limit of two packs.

Pharmacy leaders back change

Pharmacy leaders also backed making paracetamol a pharmacy-only drug. Numark director of pharmacy services Mimi Lau said that, unless the MHRA’s guidelines “are made into law and breaches lead to consequences”, paracetamol sales should be restricted to within pharmacies.

This would ensure the drug can only be brought where appropriate and necessary advice can be exercised”, she said. “Safety of patients has got to be the number one priority,” she stressed.

Royal Pharmaceutical Society president Ash Soni also argued that, if retailers are not “prepared to change” their practices, then the “ultimate solution has to be that [paracetamol] becomes available only through pharmacy”.

“What’s really important in all cases is that medicines should not be seen as ordinary items of commerce,” he added.

National Pharmacy Association chief pharmacist Leyla Hannbeck told C+D that selling paracetamol in pharmacies is “much more safe” for patients. Pharmacists are regulated and obligated to “ask the right questions” before selling the drug, she added.

Do you think making paracetamol a P medicine could increase patient safety?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Sign in or register for free

Latest from News

All the headlines: Community pharmacy funding deal

 
• By 
 • comment

Find out everything you need to know about the government’s plans for community pharmacy – as outlined in this week’s long-awaited pharmacy funding deal.

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Revealed: 2024/25 contract cash uplift already paid

 
• By 
 • comment

Following this week’s announcement of the long-awaited pharmacy funding deal, C+D has learned that contractors have already received the additional £106 million in retrospective funding for 2024/25.

More from Clinical

exclusive

Exclusive: Pharmacists now able to read patient GP records

 
• By 
 • comment

Community pharmacies now have access to a patient’s GP record at the point of delivering any NHS clinical pharmacy service, C+D has learned.

Semaglutide not linked to increased suicide risk, study finds

 
• By 
 • comment

A new study has revealed that the use of GLP-1RAs such as semaglutide are “not associated” with an increased risk of suicidality among patients with type 2 diabetes.